Hans has devoted his entire career to the development and registration of veterinary biologicals. He has worked for major corporations including Pfizer Animal Health, SmithKline Beecham, and Beecham Laboratories, holding various senior regulatory and R&D management roles. Hans has developed and licensed vaccines for all major species with the USDA Center for Veterinary Biologics and other global regulatory agencies.
Education
- South Dakota State University, BS in Microbiology, 1975
- South Dakota State University, MS in Microbiology, 1978
Gourdneck View Consulting, LLC 2012 – 2013
President, Gourdneck View Consulting, LLC, GVC specializes in Veterinary Biologics including all aspects of Regulatory Affairs from company start-up to global expansion, development planning, study design and report generation, problem solving (R&D, manufacturing and QC), emerging diseases, training and development, mergers and acquisitions, Department of Commerce EAR requirements and international harmonization.
These services are now incorporated in EDGE Veterinary Vaccines Consulting Group, LLC
Pfizer Animal Health 1996-2011
Senior Director, Biological Regulatory Affairs, responsible the Registration of Veterinary Biologicals in North America, and global biological regulatory and technical support.
SmithKline Beecham 1994-1996
Director, Project Development, responsible for the coordinating the development of Veterinary Biologicals on a global basis.
SmithKline Beecham 1989-1994
Associate Director, Biological Regulatory Affairs, responsible for Global Biological Regulatory Affairs.
Beecham Laboratories 1982-1989
Manager of Biological R&D, responsible development and registration of veterinary vaccines.
Beecham Laboratories 1979-1982
Virology Project Leader, lead research group developing virus vaccines.
Draayer, HA, The Reduction of Animal-based Safety Testing of Veterinary Vaccines,Progress, Possibilities, and Challenges; a North American Perspective, Eighth World Congress on Alternatives and Animal Use in the Life Sciences, Montréal Canada August 21-25, 2011
Draayer, HA, The Veterinary Biologics Industry Response to Emerging Disease, 1st International One Health Congress, Melbourne, Australia, February 14-16 2011
Draayer, HA, Overview of Currently Approved Veterinary Vaccine Potency Testing Methods and Methods in Development that Do Not Require Animal Use, International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine Potency and Safety Testing: State of the Science and Future Directions, NICEATM-ICCVAM workshop on alternative methods for vaccine potency and safety testing, NIH, Bethesda, MD, USA, Sept. 14-16 2010
Draayer, HA, The Veterinary Biological Development Odyssey – A RegulatoryPerspective, Midwest Regional Chapter Society Of Quality Assurance, Madison, WI July 29-30 2008
Draayer, HA, Autogenous Vaccines: Determining Product Need and Antigen Selection, Production and Testing Considerations, Considerations of Alternative Licensing Procedures for Vaccines for Minor Species, Minor Indications and Autogenous/Autologous Products, PEI, Langen, Germany, October 29-31, 2003
